0001415889-24-010505.txt : 20240408 0001415889-24-010505.hdr.sgml : 20240408 20240408171826 ACCESSION NUMBER: 0001415889-24-010505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240404 FILED AS OF DATE: 20240408 DATE AS OF CHANGE: 20240408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Megna Michael R CENTRAL INDEX KEY: 0001464583 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 24830484 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-04082024_090419.xml X0508 4 2024-04-04 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001464583 Megna Michael R C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF ACCOUNTING OFFICER 0 Class A Common Share 2024-04-08 4 M 0 3932 A 22994 D Class A Common Share 2024-04-08 4 F 0 1666 17.90 D 21328 D Share Option 18.06 2024-04-04 4 A 0 18900 0 A 2034-03-31 Class A Common Share 18900 18900 D Restricted Share Unit 2024-04-04 4 A 0 9450 0 A Class A Common Share 9450 17122 D Restricted Share Unit 2024-04-08 4 M 0 3932 0 D Class A Common Share 3932 13190 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2024. The RSUs vest over a four year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. /s/ Madelyn Zeylikman, Attorney-in-Fact 2024-04-08